Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.
about
Modulation of GITR for cancer immunotherapyNovel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection.Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis.Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.Integrating costimulatory agonists to optimize immune-based cancer therapies.Combination immune therapies to enhance anti-tumor responses by NK cells.Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.Central and peripheral nervous systems: master controllers in cancer metastasis.Genomic expression profiling of NK cells in health and disease.Generation and preclinical characterization of a Fc-optimized GITR-Ig fusion protein for induction of NK cell reactivity against leukemia.4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia.Enhanced in vitro refolding of soluble human glucocorticoid-induced TNF receptor-related ligand.Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression.GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.CD8+ T cells: GITR matters.
P2860
Q26853557-43371F71-33B7-4F80-8D28-74D082D59831Q34778972-2232FC82-3ADB-4313-BE7B-AFEBD823041EQ35139010-8D40C8F1-7F2B-48B1-A3EC-EE6CDC8A5B80Q35566828-DFBEAFFD-DFE0-4808-BE0B-A308CA689BB7Q36147260-D4ACBCC1-48C4-416E-B80F-B3F319578E9CQ37352989-3C202B60-AB28-445F-9650-BC093F3EABDDQ37408550-EF5C02E5-6E57-48C9-A412-FD7B214718E1Q37799255-621DBC3F-6498-4DAC-8955-559790051EF5Q38073762-3E9C8057-E9B6-4F45-A6E7-83557372B927Q38106901-646BF341-194E-49E1-830B-FA5A03F9D2EDQ38283442-93E52CB9-AB5B-454D-B253-F8E8109038EEQ39591125-06DACC9D-1D61-4555-8A1E-DC1612E989BFQ43671010-3E6EC547-EEF5-4471-8EFD-E3A525D3DD33Q51047152-F7604014-4779-40D4-983F-C51D1A4ACF47Q52603630-E6986C47-B9E0-4E22-A145-E3FD40AE2D11Q55059683-0092B5A9-0C74-49FC-B7F0-419DDFAEDD45Q55450551-8380B9C1-697C-49A3-BDDB-321CBBF2F7D6
P2860
Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Glucocorticoid-induced tumor n ...... increasing NK cell apoptosis.
@ast
Glucocorticoid-induced tumor n ...... increasing NK cell apoptosis.
@en
type
label
Glucocorticoid-induced tumor n ...... increasing NK cell apoptosis.
@ast
Glucocorticoid-induced tumor n ...... increasing NK cell apoptosis.
@en
prefLabel
Glucocorticoid-induced tumor n ...... increasing NK cell apoptosis.
@ast
Glucocorticoid-induced tumor n ...... increasing NK cell apoptosis.
@en
P2093
P2860
P50
P356
P1476
Glucocorticoid-induced tumor n ...... d increasing NK cell apoptosis
@en
P2093
Baoying Liu
Sankaranarayana P Mahesh
Willie O Siu
Zhuqing Li
P2860
P304
P356
10.1074/JBC.M708944200
P407
P577
2008-01-29T00:00:00Z